Question 1

What is the catalog number for Dicyclohexylamine 99% For Synthesis?

Accepted Answer

The catalog number for Dicyclohexylamine 99% For Synthesis is 00978 00500.

Question 2

What sizes are available for Dicyclohexylamine 99% For Synthesis?

Accepted Answer

Dicyclohexylamine 99% For Synthesis is available in the following size(s): 500 mL.

Question 3

Is Dicyclohexylamine 99% For Synthesis in stock?

Accepted Answer

Dicyclohexylamine 99% For Synthesis is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Dicyclohexylamine 99% For Synthesis

Product Specifications

CAS Number

HS Code

Packaging Group

Frequently Asked Questions

Explore Other Products

Anti-SNRPD2 Antibody Picoband®, HRP Conjugate

TAG-72 / CA72.4 (Tumor-Associated Glycoprotein) (CA72/2869R), 0.2mg/mL

STAT6 (Solitary Fibrous Tumor Marker) (STAT6/2410), CF740 conjugate, 0.1mg/mL

P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF640R conjugate, 0.1mg/mL

Anti-TIMP1 Antibody Picoband®, PE Conjugate

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF640R conjugate, 0.1mg/mL